Zacks.com on MSN4 天
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Insulet's Omnipod 5 System is now compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the United States.
Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Insulet's financials are robust, with rising revenues, margins, and a strong cash position. Click here to read an analysis of ...
Zacks.com on MSN19 小时
If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and ...
drugdeliverybusiness6 天
Insulet Omnipod 5 is now compatible with Abbott FreeStyle Libre 2 Plus in the U.S.
Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...
drugdeliverybusiness29 天
Insulet fully launches Omnipod 5 app for iPhone in U.S.
The Omnipod 5 with the Dexcom G7 CGM. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced the full market release of the Omnipod 5 automated insulin delivery app for iPhone in the U.S.
Dexcom Glucose Data To Be Integrated With ŌURA Rings
Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help ...
Business Insider7 天
Insulet Says Omnipod 5 AID System Now Compatible With Abbott's FreeStyle Libre 2 Plus CGM ...
(RTTNews) - Insulet Corp. (PODD), a provider of tubeless insulin pump technology, announced Wednesday that the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott ...